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____________________________________________________________________26 
ABSTRACT 27 
 28 
The protein composition of bovine skim milk was modified using pilot scale 29 
membrane filtration to produce a whey protein-dominant ingredient with a casein 30 
profile closer to human milk. Bovine skim milk was processed at low (8.9 °C) or high 31 
(50 °C) temperature using ceramic microfiltration (MF) membranes (0.1 µm mean 32 
pore diameter). The resulting permeate stream was concentrated using 33 
polyethersulfone ultrafiltration (UF) membranes (10 kDa cut-off). The protein profile 34 
of MF and UF retentate streams were determined using reversed phase-high 35 
performance liquid chromatography and polyacrylamide gel electrophoresis. Permeate 36 
from the cold MF process (8.9 °C) had a casein:whey protein ratio of ~35:65 with no 37 
αS- or κ-casein present, compared with a casein:whey protein ratio of ~10:90 at 50 °C. 38 
This study has demonstrated the application of cold membrane filtration (8.9 °C) at 39 
pilot scale to produce a dairy ingredient with a protein profile closer to that of human 40 
milk. 41 
_____________________________________________________________________ 42 
43 
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1. Introduction 44 
 45 
The design of membrane-based fractionation processes for the development of 46 
enriched protein ingredients can provide an enhanced nutritional profile in infant milk 47 
formulations (IMF). The compositional differences between human and bovine milk 48 
are of particular importance for infant food formulations as the majority of infant 49 
formula is based on bovine milk (O’Mahony & Fox, 2013). The use of unmodified 50 
bovine milk as the sole source of nutrients for infants is discouraged (Morgan, 2006). 51 
Most current-generation IMFs consist of milk-derived ingredients, vegetable oils and 52 
micronutrients blended together in proportions consistent with those found in human 53 
milk (Martin, Ling, & Blackburn, 2016). The protein component of IMFs is critical to 54 
support the growth and development of infants, but achieving the correct protein 55 
profile in IMFs is complicated by milk protein heterogeneity and inter-species 56 
variation.  57 
As described by O’Mahony and Fox (2013), milk proteins can be divided into 58 
two principal families, caseins (CNs) and whey proteins (WPs), which can be further 59 
sub-divided into individual CNs (e.g., αS-CN, β-CN, κ-CN) and WPs (e.g., α-60 
lactalbumin, β-lactoglobulin, lactoferrin). The protein profile of IMFs intended for 61 
infants between 0–6 months (‘first age’) is designed to closely mimic that found in 62 
human milk. WPs account for ~60% of the total protein present in human milk, 63 
compared with only ~20% in bovine milk (de Wit, 1998); thus, IMFs are typically 64 
prepared by adjusting the CN:WP ratio of bovine milk (80:20) to that of human milk 65 
(40:60) by mixing skim milk with WP-based ingredients (e.g., whey protein 66 
concentrate and demineralised whey). The CN and WP fractions of human milk 67 
consist primarily of β-CN and α-lactalbumin, respectively, while αS-CNs and β-68 
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lactoglobulin predominate in bovine milk (Lönnerdal, 2003). Increasing the 69 
proportion of proteins such as β-CN and α-lactalbumin is an important objective in 70 
efforts to improve the nutritional properties of IMFs and can be achieved through the 71 
addition of enriched or purified protein ingredients (Fox, Uniacke-Lowe, McSweeney 72 
& O’Mahony, 2015).  73 
The need to use multiple dairy ingredients to achieve a humanised protein 74 
profile places additional burdens on IMF manufacturers in terms of ingredient 75 
sourcing/transit and prediction of ingredient functionality/stability during 76 
reconstitution, thermal processing and re-drying. An alternative strategy is here 77 
proposed where the development of ‘protein base’ ingredients, in which several of the 78 
major humanisation targets (CN:WP ratio, CN profile) are achieved in a single 79 
processing operation. Such a strategy is feasible using a process based on small-pore 80 
(0.1 µm) microfiltration (MF), described in the present study. 81 
Although there have been major developments in the manufacture of WP-82 
based ingredients for IMFs (e.g., enriched α-lactalbumin fractions, purified 83 
lactoferrin), progress in CN ingredient development has been comparatively slow. 84 
‘Cold MF’ (i.e., filtration temperature: 0 to 15 °C) of skim milk is a promising 85 
approach to generating β-CN-enriched WP-dominant ingredients for use in the 86 
production of IMFs. There are a number of studies that have demonstrated the 87 
enrichment of β-CN using MF (or sometimes UF) at temperatures < 10 °C (Crowley 88 
et al., 2015; Le Berre & Daufin, 1994; O’Mahony, Smith, & Lucey, 2014; Woychik, 89 
1992). Crowley et al. (2015) recently demonstrated the concept at laboratory scale 90 
using polyvinylidene-difluoride (PVDF, 0.1 µm pore size) or polyethersulfone (PES, 91 
1000 kDa cut-off) membranes at temperatures <5 °C. It is possible to effectively 92 
enrich β-CN from renneted milk gels (Huppertz et al., 2006), but MF has the 93 
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advantage of generating a soluble and highly-functional co-product, micellar casein 94 
concentrate (MCC). The enrichment of β-CN in the whey permeate during cold MF is 95 
based on the principle that an increasing proportion of β-CN is monomeric as 96 
temperature is decreased, with a concomitant migration of the monomers from 97 
micelles into to the serum phase (Dauphas et al., 2005; Rose, 1968). β-CN can be 98 
manufactured at relatively high purity (70–80% of total protein) by cold MF of liquid 99 
MCC (Christensen & Holst, 2014) or warm MF (>26 °C) of the β-casein-enriched 100 
whey permeate generated from cold MF of milk; however, for the production of WP-101 
dominant IMFs pure β-casein is not an essential requirement, as the presence of WPs 102 
in the ingredient is likely preferable.  103 
Most of the MF processes that have been described for β-CN enrichment have 104 
used cold temperatures and polymeric membranes, and have been associated with low 105 
permeate flux values, due to a combination of high feed viscosity and severe fouling 106 
of the membrane. Strategies to improve flux are primarily restricted to adjusting the 107 
type of membrane; for example, it has been shown that flux-enhancement in a cold 108 
MF process can be achieved by using PES rather than PVDF membranes (Crowley et 109 
al., 2015). However, it can be predicted that a switch to ceramic membranes would 110 
facilitate operation at much higher flux values. While the surface area of ceramic 111 
membrane configurations may not be as large as for spiral-wound polymeric systems, 112 
they have the advantage of being compatible with technology designed to ensure a 113 
consistent trans-membrane pressure (TMP) across the length of the membrane. An 114 
example of this technology is the Isoflux® membrane, in which the active layer 115 
decreases in thickness from inlet to outlet, so that the pressure:thickness ratio, and 116 
therefore flux, is theoretically constant along the hydraulic path (Adams & Barbano, 117 
2013). 118 
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The objective of this study was to produce an ingredient from skim milk for 119 
application as a protein base during IMF manufacture. The target protein profile for 120 
the ingredient was a CN:WP ratio close to that of human milk, in which the CN 121 
fraction consisted primarily of β-CN. The ingredient was prepared using MF and DF 122 
of skim milk at low temperatures using ceramic Isoflux® membranes, followed by 123 
concentration using UF. A cold MF process was carried out and compared with the 124 
more traditional warm MF in terms of process performance (i.e., permeate flux) and 125 
nutrient partitioning (i.e., minerals, proteins, non-protein nitrogen and fat). 126 
 127 
2.  Materials and methods 128 
 129 
2.1.  Materials 130 
 131 
Raw bovine whole milk was obtained from the Teagasc Grassland Research 132 
Centre, with the fat separated centrifugally at 50 °C using facilities at Moorepark 133 
Technology Limited (Fermoy, Co. Cork, Ireland). Urea, bis-tris propane, and 2-134 
mercaptoethanol were obtained from Sigma (Wicklow, Ireland). The electrophoresis 135 
chemicals were obtained from Bio-Rad (Fannin, Dublin, Ireland). All other chemicals 136 
used were of analytical grade. Milli-Q water (Millipore, Ireland) was used for all 137 
solutions.  138 
 139 
2.2.  Compositional analysis 140 
  141 
 Total nitrogen, non-protein nitrogen and true protein were determined using 142 
the Kjeldahl method (ISO, 2001a,b,c), and a nitrogen-protein conversion factor of 143 
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6.38. Fat content was determined using the Gerber method (IDF, 1991). Mineral 144 
analysis was determined by an Agilent 7700s inductively-coupled plasma mass 145 
spectrometry (ICP-MS) (Agilent Technologies, Santa Clara, California, USA).  146 
 147 
2.3.  Pilot-scale membrane filtration and powder manufacture 148 
 149 
Skim milk (300 kg) was diluted prior to filtration by adding 600 kg of reverse 150 
osmosis (RO) water. In-house testing has shown that diluting unheated skim milk 151 
prior to filtration increased the dissociation and solubilisation of β-casein. The diluted 152 
skim milk was held at ~4 °C for 16 h, before holding at 8.9 °C or heating to 50 °C 153 
prior to membrane filtration. The diluted skim milk was subject to MF using 0.14 µm 154 
pore size Tami Isoflux® ceramic membranes (Tami Industries, Nyons Cedex, France) 155 
on a GEA Model F filtration unit (GEA Process Engineering A/S, Skanderborg, 156 
Denmark) with complete retentate recycling (i.e., retentate is returned to the feed). 157 
Three ceramic  membranes were used in parallel, each with an area of 0.35 m-2. The 158 
temperature throughout processing was maintained at 8.9 ± 1.2 °C or 50 ± 1.0 °C 159 
using an in-line heat exchanger. The feed recirculation rate was adjusted to 1500 L h-1 160 
at a feed pressure of 1 bar and a membrane inlet pressure of 2.7 bar (0.9 bar per 161 
membrane element). The permeate flux was measured gravimetrically throughout 162 
filtration until a volume concentration factor (VCF) of 3 was reached. VCF was 163 
calculated by dividing the feed volume (Vf) by the final retentate volume (Vr): 164 
Volume concentration factor 
r
f
V
V
VCF =       (1) 165 
All permeate streams from MF were subsequently subjected to UF with two 166 
10 kDa cut-off Synder spiral-wound membranes (Synder Filtration, CA, USA) 167 
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arranged in series in the Model F filtration unit. UF was performed at a temperature of 168 
50 ± 1.0 °C for all trials with a feed recirculation rate of 1600 L h-1 at 1 bar pressure 169 
and a membrane inlet pressure of 1.8 bar. A final VCF of 14 was attained. Permeation 170 
behaviour of individual proteins through MF membranes were characterised using the 171 
sieving coefficient (So). 172 
R
P
o C
CS =  (2) 173 
where Cp and CR are the simultaneous concentration of the protein in the permeate and 174 
retentate, respectively.  175 
Membrane filtration performance was monitored using permeate flux 176 
measurements taken during each MF concentration run (Fig. 1A); solids content of the 177 
feed was also monitored (Fig. 2B); the starting feed material was skim milk (9.3% 178 
solids) diluted to ~3.1% solids with RO water. The solids content and pH of the 179 
original skim milk and rehydrated powders (protein content 3.3%, w/w) were 180 
measured using a CEM Smart Trac moisture analyser (Damastown, Dublin, Ireland) 181 
and a WTW 3310 pH meter (WTW, Weilheim, Germany), respectively. 182 
Retentate streams obtained from MF and UF were heated to 30 °C prior to 183 
evaporation using a Tetra Scheffers™ single-stage falling-film evaporator operated at 184 
60 °C (Tetra Pak, Gorredijk, The Netherlands). The concentrate was spray-dried using 185 
a pilot scale Anhydro Lab 3 spray dryer (SPX Flow Technology A/S, Soeborg, 186 
Denmark), equipped with a wheel atomiser. Inlet and outlet temperatures were set at 187 
178 °C and 88 °C, respectively. Powder samples were coded as follows: MFRwarm, 188 
dried retentate from MF of skim milk at 50 °C; MFRcold, dried retentate from MF of 189 
skim milk at 8.9 °C; UFRwarm, dried retentate from UF of warm (50 °C) MF permeate; 190 
UFRcold, dried retentate from UF of cold (8.9 °C) MF permeate.  191 
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Membrane filtration processes at 50 and 4 °C were carried out in triplicate 192 
from a total of six different batches of skim milk, producing three independent 193 
powder samples for each of MFRwarm, MFRcold, UFRwarm and UFRcold.  194 
 195 
2.4.      Protein profile analysis 196 
 197 
Protein profile analysis of MF and UF retentate powder samples was carried 198 
out using reverse phase-high performance liquid chromatography (RP-HPLC) and 199 
sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) to quantify 200 
individual protein fractions and to observe the presence of minor whey protein 201 
components, respectively.   202 
 203 
2.4.1.  Reversed phase-high performance liquid chromatography  204 
All MF retentate and UF retentate powder samples were dispersed in buffer 205 
containing 7 M urea, 20 mM bis-tris propane and 71.5 mM 2-mercaptoethanol (pH 7.5) 206 
in a 1:20 ratio (v/v) at room temperature. Each sample was incubated for 1 h at room 207 
temperature before being filtered (pore size of 0.22 µm). A 5 µL aliquot of each 208 
sample was injected three times into a Poroshell 300SB-C18 (Size: 2.1 × 7.5 mm, 5 209 
µm; Agilent Technologies, Ireland) column equipped with a Zorbax poroshell guard 210 
column (Size: 1.0 × 17 mm, 5 µm; Agilent Technologies). The HPLC was equipped 211 
with a UV-vis detector (61365D MWD Agilent Technologies 1200 series). The 212 
column was operated at temperature 35 °C at a flow rate of 0.5 mL min-1 and was 213 
equilibrated in 74% solvent A (0.1% trifluoroacetic acid and 10% acetonitrile in 214 
MilliQ water) and 26% B (0.1% trifluoroacetic acid and 10% MilliQ water in 215 
acetonitrile). A series of linear gradients were then applied by raising the 216 
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concentration of solvent B to 37% over 10 min, then to 45% over 23 min, and to 217 
100% over 3.5 min. Solvent B was held at 100% for 4.5 min before reducing its level 218 
over 34 min back to the initial level of 26% where it was held for 2.5 min. Detection 219 
was by absorbance at 214 nm and total run time was 36.5 min per sample. HPLC 220 
analysis was carried out in triplicate 221 
 222 
2.4.2. Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 223 
SDS-PAGE analysis was performed based on the methods of Laemmli (1970) 224 
and modified as described by Oldfield, Singh, Taylor, and Pearce (2000). Reducing 225 
SDS-PAGE was run with the addition of 2-mercaptoethanol, with heating at 95 °C for 226 
5 min. Gels were run on a Mini-Protean III dual cell system (Bio-Rad Laboratories, 227 
Hercules, CA, USA). Mini-Protean TGX gels (anyKda, 10 wells; Bio-Rad) were used 228 
in the analyses. MF retentate and UF retentate powder samples were diluted to 0.13% 229 
(w/w, protein basis) with the appropriate sample buffer before loading. Subsequently, 230 
the corresponding sub-samples were loaded accurately (10 µL per well) into the 231 
sample wells using a micro-pipette. lectrophoresis was carried out at 200 V. The 232 
bands were stained with 0.1% (w/v) Coomassie Brilliant Blue G250 in 34% methanol 233 
for 24 h and destained in a solution containing 10% (v/v) glacial acetic acid and 10% 234 
(v/v) isopropanol. The destaining solution was changed every 4 h to obtain a light 235 
background on the gel. Destained gels were scanned on Epson Scan Perfection V700 236 
Photo scanner (Epson, Hertfordshire, UK) and the protein bands were identified using 237 
the software program, ImageQuant (GEHealth care, Ireland).  238 
 239 
2.5. Statistical analysis 240 
 241 
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Fisher’s one-way multiple-comparison test was used as a guide for pair 242 
comparisons of the mean permeate flux values and the powder compositional data 243 
produced from membrane filtration. The level of significance was determined at P < 244 
0.05 using Minitab 17 (Minitab Ltd, Coventry, UK) statistical analysis package and 245 
the effects of treatment and replicates were estimated for each response variable.  246 
 247 
3.  Results and discussion 248 
 249 
3.1. Membrane filtration process performance 250 
 251 
The performance of the MF process under warm (50 °C) and cold (8.9 °C) 252 
conditions can be compared in Fig. 1A. Pre-dilution of the skim milk 16 h prior to MF 253 
was performed to promote β-CN dissociation. Low temperature increases serum-254 
phase β-CN by reducing hydrophobic interactions, while both cold processing and 255 
milk dilution partially dissolve colloidal calcium phosphate (CCP), further increasing 256 
transmission of β-CN (Broyard & Gaucheron, 2015).  Initial permeate flux (time 0) of 257 
~380 L m-2 h-1 for warm MF rapidly decreased to ~307 L m-2 h-1 after 0.25 h; flux 258 
remained relatively constant at this value until ~1.7 h of processing and a solids 259 
content of ~4.5% when a sudden and dramatic decline in flux to <150 L m-2 h-1 260 
occurred (Fig. 1A). Once the retentate reached ~75% protein (w/w, dry matter) the 261 
MF rig was shut down, coinciding with a total process time of ~3 h and a final solids 262 
content of 12.2%, w/w. Previous studies for the MF of skim milk at 50 °C have 263 
reported much lower permeate flux values than those measured in the current study; 264 
for example, Hurt, Zulewska, Newbold, and Barbano (2010) obtained a constant 265 
permeate flux for skim milk of ~54.0 L m-2 h-1 using ceramic membranes with a pore-266 
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size of 0.1 µm, operated under uniform trans-membrane pressure (0.42 bar) at 50 °C. 267 
The high flux rates shown in Fig. 1 are probably due to a combination of a high 268 
retentate flow rate (1500 L h-1) and the use of highly dilute skim milk as the feed. MF 269 
carried out at 8.9 °C had a significantly (P < 0.05) lower initial permeate flux (~98 L 270 
m-2 h-1; Fig. 1A), compared with MF at 50 °C (~380 L m-2 h-1; Fig. 1A). Permeate flux 271 
continued to decrease in a linear manner throughout filtration (Fig. 1A), reaching a 272 
value of 52 L m-2 h-1 after ~13 h.  273 
Although the average permeate flux was much lower for cold MF compared 274 
with the warm MF process, the extent of flux decline was much less for the former, 275 
due to reduced fouling (Fig. 1), in agreement with other research demonstrating the 276 
benefits of cold membrane processing. Luo, Ramchandran, and Vasiljevic (2015) 277 
compared the performance of UF membranes during processing of milk at 15, 30 or 278 
50 °C and found a more rapid flux decline at the highest UF temperature due to 279 
increased protein- and calcium-based fouling.  Similarly, Méthot-Hains et al. (2016) 280 
found that flux decline during UF of skim milk was more rapid at 50 °C than at 10 °C 281 
as the VCF increased from 1 to 4. The flux values shown in the present work for cold 282 
MF were significantly higher than values reported in previous studies for cold MF 283 
processes; although, diafiltration water was added upfront to the skim milk in the 284 
current study, which would significantly increase permeate flux. For example, 285 
O’Mahony et al. (2014) obtained an initial permeate flux of ~10 L m-2 h-1 during the 286 
enrichment of β-CN from skim milk using polymeric membranes at 3–6 °C.  287 
 288 
3.2.  Composition and physicochemical properties of dried retentates  289 
 290 
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The composition and physicochemical properties of MF and UF retentate 291 
powders after spray drying are shown in Table 1. Fat content increased in the MF 292 
retentates compared with the original skim milk, with very low levels of fat present in 293 
the UF retentates. There was a significantly (P < 0.05) lower fat content in UFRcold, 294 
indicating that milk fat had lower transmission at the low temperature during cold 295 
MF.  296 
The mineral composition of powders from MF and UF retentate streams are 297 
given in Table 3. Calcium and phosphorous levels decreased in MFRcold compared 298 
with MFRwarm; in turn, UFRcold had a higher calcium and phosphorous content 299 
compared with the UFRwarm powder. Similarly, Méthot-Hains et al. (2016) found that 300 
the permeation of calcium increased during UF of milk with 10 kDa PES spiral-301 
wound membranes at 10 °C compared with 50 °C, due to an increase in soluble 302 
calcium at low temperatures. Magnesium, sodium and potassium were all 303 
significantly (P < 0.05) higher in UF retentates compared with MF retentate powders, 304 
while the temperature of MF processing had no significant effect (P > 0.05) on their 305 
transmission (Table 3). Therefore, MF temperature can be said to have only had an 306 
effect on the major components of CCP. The pH of MF and UF retentate streams were 307 
significantly (P < 0.05) higher than that of the diluted skim milk, likely due to the loss 308 
of these soluble minerals along with citric acid that would otherwise act as buffering 309 
salts (Table 1). Hurt et al. (2010) found a similar result during the MF of skim milk at 310 
50 °C, when the pH of the retentate fraction increased from pH 6.6 to pH 7.0.  311 
 312 
3.3.  Protein profile of retentate streams from microfiltration and ultrafiltration  313 
 314 
3.3.1.  β-Casein transmission and casein:whey protein ratio 315 
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MF of skim milk at 50 or 8.9 °C resulted in very different protein profiles 316 
(Table 2). MF of skim milk at 50 °C facilitated extensive depletion of whey proteins 317 
with almost complete retention of casein (Fig. 2; lane 3 MFRwarm). UFRwarm powders 318 
contained primarily whey proteins (91.2% of protein) and a minor quantity of β-CN 319 
(8.81% of protein). SDS-PAGE profiles (Fig. 2; lane 1 UFRwarm) and HPLC 320 
chromatograms (Fig 3; profile E) indicated the presence of some β-CN in UFRwarm 321 
powders, quantified at 8.81% of total protein, with the remaining 91.2% consisting of 322 
WPs (Table 2). The average So of β-CN during MF at 50 °C was 0.07, which was 323 
significantly lower than the value of 0.26 measured during MF at 8.9 °C (Table 2; Fig. 324 
3E).  325 
Due to the high So values reached for β-CN and whey proteins during cold 326 
MF the UFRcold powder had a CN:WP ratio of 35:65 with 100% of the CN comprised 327 
of β-CN (Table 1); this protein profile is close to that found in human milk and 328 
compares favourably in this respect with previous reports of MF processes involving 329 
similar pore-size membranes. For example, Woychik (1992) enriched β-CN using 0.1 330 
µm MF membranes at 4 °C; however, the β-CN purity was low (55% of total CN) and 331 
the system was CN-dominant (55:45 CN:WP). Glas, te Biesebeke, Kromkamp and 332 
Klarenbeek (2013) reported enriching β-CN from skim milk using MF with 0.15 µm 333 
membranes at 10 °C, which resulted in a low CN:WP ratio of 14:86 and a high β-CN 334 
purity of 95% (total CN basis). Crowley et al. (2015) measured a β-CN purity of 335 
100% and a CN:WP ratio of 49:51 when a permeate generated at <4 °C using a 0.1 336 
µm MF membrane was analysed. The process described in the present study achieves 337 
a balance of appropriate CN:WP ratio and excellent β-CN purity (confirmed using 338 
Maldi-TOF analysis; results not shown). 339 
 340 
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3.3.2.  Whey protein transmission and proteolysis products 341 
Cold MF resulted in greater retention of β-lactoglobulin (Fig. 2; lane 4), 342 
compared with warm MF (Fig. 2; lane 3). Gésan-Guiziou, Daufin, and Boyaval 343 
(2000) studied the factors affecting the transmission of β-lactoglobulin during MF of 344 
skim milk at 50 °C and showed that above the critical flux (i.e., pressure independent 345 
region) β-lactoglobulin transmission decreased significantly, due to modified fouling 346 
layer characteristics. The hindered protein transmission observed for cold MF in this 347 
study may also be caused by altered sieving characteristics due to an altered fouling 348 
layer; the increased hydrodynamic volume of the micellar phase at low temperatures 349 
(Liu, Weeks, Dunstan, & Martin, 2013) could be a possible explanation for this effect. 350 
The detection of a band with a molecular mass of ~12 kDa in SDS-PAGE 351 
analysis of MF retentate streams may be the result of casein proteolysis occurring 352 
during membrane filtration (Fig. 2; lanes 3 and 4). Its absence from UF retentate 353 
powders indicated that, while lower in molecular mass than α-lactalbumin, it may be 354 
associated with the CN micelle and thus not be transmittable during MF. The band 355 
appeared fainter in MFRcold powders (Fig. 2; lane 4) than in MFRwarm powders (Fig. 2; 356 
lane 3), indicating that proteolysis may have been more prevalent at 50 °C than at 8.9 357 
°C. Hurt et al. (2010) found the presence of a similar band in SDS-PAGE gels of MF 358 
retentate streams after filtration of skim milk at 50 °C using 0.1 µm pore sized UTP 359 
ceramic membranes. Jost, Brandsma, and Rizvi (1999) identified the band as proteose 360 
peptone component 5 (β-casein 1–105/1–107; Andrews, 1978) and suggested that the 361 
phosphoprotein remains associated with the casein micelle during MF and therefore 362 
does not permeate 0.1 µm MF membranes even though its molecular mass is much 363 
less. 364 
 365 
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4.  Conclusion 366 
 367 
Cold MF and DF facilitated the formulation of a protein base with a casein 368 
profile close to human milk using a skim milk feed. Using this process it was 369 
demonstrated that two major formulation targets, a CN:WP ratio (40:60) and CN 370 
profile (β-CN), can be achieved. Other potential benefits of the cold MF and DF 371 
process were also identified, ranging from a reduction in β-lactoglobulin levels and 372 
reduced in-process proteolysis (lower levels of casein hydrolysis products). The 373 
manufacture of suitable infant formula protein base ingredients using integrated 374 
membrane systems will be an important development in next-generation IMF 375 
processing. Future work could also focus on the re-micellisation of β-CN through 376 
addition of κ-casein, to more closely mimic the protein profile of human milk while 377 
increasing heat stability.  378 
 379 
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Figure legends 1 
 2 
Fig. 1. Membrane filtration time of microfiltered diluted skim milk, measured as (A) a 3 
function of permeate flux (L m-2 h-1) and (B) total solids at 50 °C () and 8.9 °C (). 4 
 5 
Fig. 2. Reducing SDS-PAGE patterns (4–20% acrylamide gel) of retentate powders 6 
from microfiltered and ultrafiltered skim milk. Lane 1, UF retentate produced after 7 
microfiltration at 50 °C (UFRwarm); lane 2, UF retentate produced after microfiltration 8 
at 8.9 °C (UFRcold); lane 3, MF retentate produced by microfiltration at 50 °C 9 
(MFRwarm); lane 4, MF retentate produced by microfiltration at 8.9 °C (MFRcold); lane 10 
5, α-lactalbumin standard; lane 6, β-lactoglobulin standard; lane 7, lactoferrin 11 
standard. 12 
 13 
Fig. 3. Reversed-phase HPLC profiles of (A) skim milk, (B) microfiltration retentate 14 
at 50 °C (MFRwarm), (C) microfiltration retentate at 8.9 °C (MFRcold), (D) UF retentate 15 
produced after microfiltration at 8.9 °C (UFRcold) and (E) UF retentate produced after 16 
microfiltration at 50 °C (UFRwarm); eluate was measured at 214 nm. 17 
 18 
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1 
 
Table 1 1 
 2 
Composition of microfiltration and ultrafiltration retentates after processing at 50 or 8.9 °C.a 3 
 4 
 5 
Parameter Skim milk   MFRwarm   MFRcold   UFRwarm   UFRcold 
Protein (%, w/w, dry basis)          
    TPN 37.8 ± 2.1   74.3 ± 0.8  72.1 ± 2.2  44.2 ± 1.0  34.4 ± 2.2  
    NPN 0.03 ± 0.0  0.10 ± 0.0  0.01± 0.0  0.03 ± 0.0  0.03 ± 0.0 
Fat (%, w/w, dry basis) 0.01 ± 0.0  0.81 ± 0.9  0.80 ± 0.6  0.40 ± 0.1  0.24 ± 0.2 
Moisture content (%, w/w)   4.37 ± 0.8  4.69 ± 0.8  2.58 ± 0.5  2.21 ± 0.7 
pH 6.64 ± 0.05   7.30 ± 0.1   7.22 ± 0.1   7.06 ± 0.0   7.08 ± 0.1 
 6 
a
 Abbreviations are: MFRwarm, retentate of microfiltration performed at 50 °C; MFRcold, retentate of microfiltration performed at 8.9 °C; 7 
UFRwarm, ultrafiltration retentate after warm (50 °C) microfiltration; UFRcold, ultrafiltration retentate after cold (8.9 °C) microfiltration; TPN, true 8 
protein nitrogen; NPN, non-protein nitrogen. 9 
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Table 2 10 
 11 
Protein profile of ultrafiltered retentate powders after processing at 50 or 8.9 °C. a 12 
 13 
Protein Skim milk   UFRwarm   UFRcold 
Total casein (%, w/w, of TP) 85.9a  8.81b   35.5c 
αS-Casein (%, w/w, of TC) 50.1a   0.00b  0.00c 
β-Casein (%, w/w, of TC) 39.6a  8.81b  35.5c 
κ-Casein (%, w/w, of TC) 10.3a  0.00b  0.00c 
      
Total whey protein (%, w/w, of TP) 15.6a  91.2b  64.5c  
α-La (%, w/w, of TW) 17.7a   19.1b   17.9c 
β-Lg (%, w/w, TW) 82.3a    72.0b    46.6c  
 14 
a
 Abbreviations are: UFRwarm, ultrafiltration retentate after warm (50 °C) microfiltration; UFRcold, ultrafiltration retentate after cold (8.9 °C) 15 
microfiltration; α-La, α-lactalbumin; β-Lg, β-lactoglobulin; TP, total protein; TC, total casein; TW, total whey protein. Values are the means of 3 16 
replicates ± standard deviations; values within a row not sharing a common superscript letter differ significantly, P < 0.05. 17 
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3 
 
Table 3 18 
 19 
Mineral profile of microfiltration and ultrafiltration retentate powders obtained at 50 or 8.9 °C. a 20 
 21 
Process Calcium  Magnesium Sodium Phosphorous Potassium 
MFRwarm  35.6a 1.65a 2.22a 24.2a 10.3a 
UFRwarm 24.2b 4.34b 23.8b 20.6b 70.4b 
MFRcold  30.9c 1.81a 2.84a 22.7a 12.2a 
UFRcold 29.2d 4.44b 31.4b 27.5c 66.3b 
 22 
a
 MFRwarm, microfiltration retentate performed at 50 °C; MFRcold, microfiltration retentate performed at 8.9 °C; UFRwarm, ultrafiltration retentate 23 
after warm (50 °C) microfiltration; UFRcold, ultrafiltration retentate after cold (8.9 °C) microfiltration. All ultrafiltration processing was 24 
performed at 50 °C. Values (mg g-1 of protein) are the means of 3 replicates ± standard deviations; values within a column not sharing a common 25 
superscript letter differ significantly, P < 0.05. 26 
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